Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Bayer symbol

Bayer’s BlueRock Therapeutics gains FDA fast track for Parkinson’s disease cell therapy

In 2019, Bayer bought out its private equity partner Versant Ventures and founders in BlueRock Therapeutics for $240m

Take part in research with Oxford University Press (OUP)

The Research Team at OUP is currently looking for professionals working in healthcare communication, education, marketing or advertising to take part in some upcoming research.

Oxford University Press

- PMLiVE

BioNTech plans acquisition of Kite’s TCR cell therapy R&D platform

German biotech company said the acquisition will boost its presence in the US

- PMLiVE

Maxwellia works with 11 London for social promotion of first ever OTC contraceptive pill

We’re excited to announce that we are now working with pioneering British pharma company Maxwellia to help launch Lovima®, a contraceptive pill to be available in pharmacies without the need...

11 London

- PMLiVE

Kriya Therapeutics raises $100m to further develop gene therapies with ‘broader applications’

Kriya is aiming to advance lower cost gene therapies with ‘broader applications’ for disease such as type 1 and type 2 diabetes

The living wall and neon sign at the Onyx Health studio

Onyx Health Launch Creative Studio After Record Year

Healthcare marketing communications specialists Onyx Health have set up a new creative studio following a year of record income growth and international client expansion.

Onyx Health

Dont fight it alone

Tyson Fury takes on his Invisible Opponent in hard hitting ad for suicide prevention charity Campaign Against Living Miserably

New campaign created by Seven Stones and AMV BBDO, digitally removes opponent Deontay Wilder from footage of their epic first bout, calling out “Don’t fight it alone”

SEVEN STONES COLLECTIVE

- PMLiVE

The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor

Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals how life...

Avalere Health

- PMLiVE

GSK reveals plans for £400m R&D facility expansion in England

GSK has formally started the process of seeking a development partner for the expansion plans

- PMLiVE

Keytruda scores a win in treating early-stage breast cancer pre- and post-surgery

The FDA had previously rejected a supplemental biologics licence application in this indication

- PMLiVE

Summer Fridays are back at Lucid Group

Summer Fridays are back, bringing some much deserved R&R for our people.☀️A ‘Summer Friday’ means that employees are now actively encouraged to finish work from 2 pm on alternate Fridays...

Lucid Group Communications Limited

- PMLiVE

FDA advisory committee votes against approval of AZ, FibroGen’s roxadustat

Briefing documents published earlier this week raised questions over the safety profile of roxadustat

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links